AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HEALIUS LTD

0.430

+0.0153.61%

Volume:4.73M

Turnover:2.02M

Market Cap:312.24M

PE:-0.75

High:0.440

Open:0.415

Low:0.410

Close:0.415

52wk High:1.070

52wk Low:0.300

Shares:726.13M

Float Shares:648.47M

Volume Ratio:0.55

T/O Rate:0.73%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.572

EPS(LYR):-0.572

ROE:-107.69%

ROA:1.18%

PB:1.82

PE(LYR):-0.75

Loading ...

Overview Company News Filings

Healius - Pathology Arrangements Transition to National Framework from 1 July 2026

THOMSON REUTERS

Healius - New Ramsay Agreements Have Initial Terms of Two to Five Years

THOMSON REUTERS

Healius Says Macquarie Group Ceases to Be a Substantial Holder

MT Newswires Live

Healius Says Macquarie Becomes Substantial Holder

MT Newswires Live

Healius (ASX:HLS) Valuation After FY26 Guidance Cut And Rising Pathology Labour Cost Pressures

Simply Wall St.

Is Healius (ASX:HLS) Using an Agilex Sale to Quietly Recast Its Core Pathology Focus?

Simply Wall St.

Healius Faces More Pain Ahead in Pathology -- Market Talk

BUZZ-Australia's Healius at record low on inadequate funding, budget pressure woes

Healius Issues Fiscal Year 2026 Guidance Amid Pathology Pressures; Explores Sale of Agilex Biolabs; Shares Drop 21%

MT Newswires Live

Healius Hits All-Time Stock Low After Profit Warning -- Market Talk

Stock Track | Healius Ltd Plummets 10.31% Intraday Amid Funding Shortfall, Staff Cuts and Strategic Asset Review

Healius Ltd - Expects FY 2026 Group Underlying EBIT of a$30 Mln-a$35 Mln

THOMSON REUTERS

Healius Ltd-FY26 Trading Update and Strategic Review of Assets

THOMSON REUTERS

Healius Ltd - Inadequate Funding Has Resulted in Difficult Decisions to Cut Staff, Others

THOMSON REUTERS

Healius Ltd - Expects FY 2026 Group Underlying Ebitda of a$259 Mln-a$264 Mln

THOMSON REUTERS

Healius Ltd - Engages UBS to Explore Sale of Agilex Biolabs

THOMSON REUTERS

Healius Says Macquarie Ceases to Be Substantial Holder

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/HLS.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HLS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"HLS.AU\",,,,,undefined,":{"symbol":"HLS.AU","market":"AU","secType":"STK","nameCN":"HEALIUS LTD","latestPrice":0.43,"timestamp":1790748720000,"preClose":0.415,"halted":0,"volume":4731644,"delay":0,"changeRate":0.036144578313253045,"nameEN":"HEALIUS LTD","floatShares":648466707,"shares":726132843,"eps":-0.572,"marketStatus":"Not Yet Opened","change":0.015,"latestTime":"09-30 16:12:00 AEST","open":0.415,"high":0.44,"low":0.41,"amount":2023147,"amplitude":0.072289,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.572,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1790812800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.415,"openAndCloseTimeList":[[1790726400000,1790748000000]],"volumeRatio":0.5465674460476854,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"HLS.AU","preClose":0.415,"auctionPrice":0.43,"auctionVolume":752505,"auction":3,"marketStatus":"盘后竞价","timestamp":1790748604740}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"HLS.AU\",,,,,undefined,":{"symbol":"HLS.AU","floatShares":648466707,"roa":"1.18%","roe":"-107.69%","lyrEps":-0.572,"volumeRatio":0.5465674460476854,"shares":726132843,"dividePrice":0,"high":0.44,"amplitude":0.072289,"preClose":0.415,"low":0.41,"week52Low":0.3,"pbRate":"1.82","psRate":"0.23","week52High":1.07,"institutionHeld":0,"latestPrice":0.43,"eps":-0.572,"divideRate":0,"volume":4731644,"delay":0,"ttmEps":-0.572,"open":0.415,"prevYearClose":0.905,"prevWeekClose":0.38,"prevMonthClose":0.43,"prevQuarterClose":0.43,"fiveDayClose":0.36,"twentyDayClose":0.43,"sixtyDayClose":0.385,"dividendPayoutRate":0.3174518941928099,"dividendGrowthYears":1,"dividendGrowthRate":5.883333333333333,"fiveYearAvgDividendRate":0.13286655691160723},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HLS.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-19","symbol":"HLS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787097600000,"name":null,"time":"","dateTimestamp":1787061600000,"actualEps":null},{"date":"2026-02-18","symbol":"HLS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771369200000,"name":null,"time":"","dateTimestamp":1771333200000,"actualEps":null},{"date":"2025-08-21","symbol":"HLS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755734400000,"name":null,"time":"","dateTimestamp":1755698400000,"actualEps":null},{"date":"2025-05-09","symbol":"HLS.AU","amount":0.413,"announcedDate":"2025-05-05","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-05-12","defaultRemindTime":1746748800000,"name":"HEALIUS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-23","payableDate":"2025-05-12","currency":"AUD","dateTimestamp":1746712800000,"payDate":"2025-05-23"},{"date":"2025-02-20","symbol":"HLS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740006000000,"name":null,"time":"","dateTimestamp":1739970000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HLS.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2021-03-25","recordDate":"2021-03-26","paymentDate":"2021-04-15","value":0.065,"currency":"AUD"},{"executeDate":"2021-09-13","recordDate":"2021-09-14","paymentDate":"2021-10-08","value":0.0675,"currency":"AUD"},{"executeDate":"2022-03-24","recordDate":"2022-03-25","paymentDate":"2022-04-05","value":0.1,"currency":"AUD"},{"executeDate":"2022-09-07","recordDate":"2022-09-08","paymentDate":"2022-09-21","value":0.06,"currency":"AUD"},{"executeDate":"2025-05-09","recordDate":"2025-05-12","paymentDate":"2025-05-23","value":0.413,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HLS.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2646334548","title":"Healius - Pathology Arrangements Transition to National Framework from 1 July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2646334548","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646334548?lang=en_us&edition=fundamental","pubTime":"2026-06-26 15:09","pubTimestamp":1782457753,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nTUE60KQL5:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","BK7113","RHC.AU","BK7501","HLS.AU","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646334547","title":"Healius - New Ramsay Agreements Have Initial Terms of Two to Five Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2646334547","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646334547?lang=en_us&edition=fundamental","pubTime":"2026-06-26 15:09","pubTimestamp":1782457753,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nTUE60KQL5:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7113","BK7509","BK7124","BK7501","RHC.AU","HLS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637398188","title":"Healius Says Macquarie Group Ceases to Be a Substantial Holder","url":"https://stock-news.laohu8.com/highlight/detail?id=2637398188","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637398188?lang=en_us&edition=fundamental","pubTime":"2026-05-22 13:35","pubTimestamp":1779428151,"startTime":"0","endTime":"0","summary":"Healius (ASX:HLS) said Macquarie Group (ASX:MQG) and its controlled bodies corporate ceased to be substantial holders of the firm on Tuesday, according to a Friday Australian bourse filing.Its shares rose 2% in recent trading on Friday","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7509","HLS.AU","BK7511","BK7501","MQG.AU","BK7124","BK7046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637780965","title":"Healius Says Macquarie Becomes Substantial Holder","url":"https://stock-news.laohu8.com/highlight/detail?id=2637780965","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637780965?lang=en_us&edition=fundamental","pubTime":"2026-05-21 12:58","pubTimestamp":1779339539,"startTime":"0","endTime":"0","summary":"Healius  said Macquarie Group  and its controlled bodies corporate acquired 5.06% voting power in the firm on Monday, becoming a substantial holder, according to a Thursday Australian bourse filing.Macquarie holds 36.7 million securities of the firm.Its shares rose over 2% in recent trading on Thursday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7124","BK7509","BK7511","BK7501","HLS.AU","MQG.AU","BK7046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636509740","title":"Healius (ASX:HLS) Valuation After FY26 Guidance Cut And Rising Pathology Labour Cost Pressures","url":"https://stock-news.laohu8.com/highlight/detail?id=2636509740","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636509740?lang=en_us&edition=fundamental","pubTime":"2026-05-17 17:39","pubTimestamp":1779010770,"startTime":"0","endTime":"0","summary":"Healius trading update puts labour costs and funding pressures in focus\nHealius (ASX:HLS) has updated its FY26 guidance and flagged higher pathology labour costs following Fair Work Commission rulings, alongside no new federal funding for pathology in the recent budget.\nThe company expects Group Underlying EBITDA of A$259 million to A$264 million and Group Underlying EBIT of A$30 million to A$35 million. It is also pointing to staff cuts and collection centre closures across its pathology...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-hls/healius-shares/news/healius-asxhls-valuation-after-fy26-guidance-cut-and-rising","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-hls/healius-shares/news/healius-asxhls-valuation-after-fy26-guidance-cut-and-rising","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HLS.AU","BK7501","BK7124","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635170677","title":"Is Healius (ASX:HLS) Using an Agilex Sale to Quietly Recast Its Core Pathology Focus?","url":"https://stock-news.laohu8.com/highlight/detail?id=2635170677","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635170677?lang=en_us&edition=fundamental","pubTime":"2026-05-14 17:35","pubTimestamp":1778751307,"startTime":"0","endTime":"0","summary":"In May 2026, Healius Limited (ASX:HLS) announced it had appointed UBS Securities Australia to explore a potential sale of its standalone Agilex Biolabs unit after receiving unsolicited approaches from several credible parties, while confirming any transaction would not affect its core Pathology operations.\nThis potential divestment highlights management’s ongoing efforts to reshape the portfolio toward pathology-focused activities and crystalise value from non-core clinical trials assets...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-hls/healius-shares/news/is-healius-asxhls-using-an-agilex-sale-to-quietly-recast-its","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-hls/healius-shares/news/is-healius-asxhls-using-an-agilex-sale-to-quietly-recast-its","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7509","BK7124","BK7501","HLS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635750601","title":"Healius Faces More Pain Ahead in Pathology -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2635750601","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635750601?lang=en_us&edition=fundamental","pubTime":"2026-05-14 08:43","pubTimestamp":1778719380,"startTime":"0","endTime":"0","summary":"0043 GMT - There's more pain ahead for Healius in pathology services, suggests Jefferies. Healius now expects underlying Ebitda of A$259 million-A$264 million in FY 2026. It cited lower pathology volumes and higher costs as the reason for lower than previously expected profitability. Analyst David Stanton expects Healius's underlying Ebit will total some A$31 million in FY 2026. That implies a pathology Ebit margin of around 2%, down 30 bps on a year earlier. \"The outlook for growth in the pathology sector remains challenging--we continue to flag a decrease in FY 2026 net pathology funding of up to A$90 million,\" Jefferies says. \"Healius is not immune to this.\" ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7124","BK7509","HLS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635273431","title":"BUZZ-Australia's Healius at record low on inadequate funding, budget pressure woes","url":"https://stock-news.laohu8.com/highlight/detail?id=2635273431","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635273431?lang=en_us&edition=fundamental","pubTime":"2026-05-13 11:28","pubTimestamp":1778642893,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Healius at record low on inadequate funding, budget pressure woes** Shares of Healius HLS.AX fall as much as 23.2% to a record low of A$0.373** Stock on track to log its worst session since late-November, 2023, if losses hold ** The healthcare company says inadequate funding resulted in cutting staff, closing collection centres and regional laboratories** Adds this year's federal budget will put additional pressure on a sector, which is a critical part of Australia's primary healthcare system** Expects FY26 underlying EBIT between A$30 million and A$35 million , higher than the A$17.1 million posted last year** About 16.3 million shares change hands, 4.5 times the 30-day avg ** Down 57.7% YTD, including the session's moves  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nL6N41Q07N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","BK7501","HLS.AU","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635220610","title":"Healius Issues Fiscal Year 2026 Guidance Amid Pathology Pressures; Explores Sale of Agilex Biolabs; Shares Drop 21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635220610","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635220610?lang=en_us&edition=fundamental","pubTime":"2026-05-13 10:09","pubTimestamp":1778638166,"startTime":"0","endTime":"0","summary":"Healius (ASX:HLS) said its pathology volumes grew 1.2% and revenue 3.5% in the fiscal first half, but volumes declined by 0.4% and revenue growth came in at a slower 2.4% for the 10 months to April, a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7124","BK7501","HLS.AU","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635227962","title":"Healius Hits All-Time Stock Low After Profit Warning -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2635227962","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635227962?lang=en_us&edition=fundamental","pubTime":"2026-05-13 09:38","pubTimestamp":1778636280,"startTime":"0","endTime":"0","summary":"0138 GMT - Healius's share price drops 22% to an all-time low of A$0.38 after the Australian healthcare company warned on profits. Healius now expects underlying Ebitda of A$259 million-A$264 million in FY 2026. That's well below RBC's A$277 million forecast ahead of today's update. Analyst Craig Wong-Pan says the update implies Healius's pathology volumes deteriorated from 1.2% growth in 1H to a 2.8% decline in the four months through April, while pathology revenue growth fell to 0.7% in 2H so far, from 3.5% in 1H. \"We believe Healius has lost share in the 2H period given Medicare pathology volume and benefits paid growth for the three months to March were 1.9% and 1.6% respectively,\" RBC says. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","HLS.AU","BK7509","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115684614","title":"Stock Track | Healius Ltd Plummets 10.31% Intraday Amid Funding Shortfall, Staff Cuts and Strategic Asset Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1115684614","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115684614?lang=en_us&edition=fundamental","pubTime":"2026-05-13 08:02","pubTimestamp":1778630564,"startTime":"0","endTime":"0","summary":"Healius Ltd's stock price plummeted 10.31% during intraday trading on Wednesday, marking a significant decline for the healthcare company.The sharp drop follows the company's announcement of...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["HLS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635722638","title":"Healius Ltd - Expects FY 2026 Group Underlying EBIT of a$30 Mln-a$35 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2635722638","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635722638?lang=en_us&edition=fundamental","pubTime":"2026-05-13 06:17","pubTimestamp":1778624276,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUE6M54QL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7509","BK7501","HLS.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635522638","title":"Healius Ltd-FY26 Trading Update and Strategic Review of Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=2635522638","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635522638?lang=en_us&edition=fundamental","pubTime":"2026-05-13 06:17","pubTimestamp":1778624276,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUE6M54QL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7509","HLS.AU","BK7501","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635263812","title":"Healius Ltd - Inadequate Funding Has Resulted in Difficult Decisions to Cut Staff, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2635263812","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635263812?lang=en_us&edition=fundamental","pubTime":"2026-05-13 06:17","pubTimestamp":1778624276,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUE6M54QL:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HLS.AU","BK7124","BK7509","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635226384","title":"Healius Ltd - Expects FY 2026 Group Underlying Ebitda of a$259 Mln-a$264 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2635226384","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635226384?lang=en_us&edition=fundamental","pubTime":"2026-05-13 06:17","pubTimestamp":1778624276,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUE6M54QL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HLS.AU","BK7501","BK7124","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635226380","title":"Healius Ltd - Engages UBS to Explore Sale of Agilex Biolabs","url":"https://stock-news.laohu8.com/highlight/detail?id=2635226380","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635226380?lang=en_us&edition=fundamental","pubTime":"2026-05-13 06:17","pubTimestamp":1778624276,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUE6M54QL:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HLS.AU","BK7124","BK7501","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627482343","title":"Healius Says Macquarie Ceases to Be Substantial Holder","url":"https://stock-news.laohu8.com/highlight/detail?id=2627482343","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627482343?lang=en_us&edition=fundamental","pubTime":"2026-04-13 14:38","pubTimestamp":1776062293,"startTime":"0","endTime":"0","summary":"Healius (ASX:HLS) said Macquarie Group and its controlled entities have ceased to be a substantial holder in the company on April 8, according to a Monday Australian bourse filing.The company's shares rose 1% in recent Monday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HLS.AU","BK7511","BK7046","BK7509","MQG.AU","BK7501","BK7124"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":37,"code":"91000000","status":"200"}]}}